Quanjun Yang
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Molecular Biology top 10%
- Muscle Physiology and Disorders
- CRISPR and Genetic Engineering
- Metabolomics and Mass Spectrometry Studies
Papers in ⓘ
-
- Muscle Physiology and Disorders 12
- CRISPR and Genetic Engineering 3
- Oncology 19
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Cheng Guo (37 shared papers)Lili Wan (19 shared papers)Yonglong Han (22 shared papers)Xipeng Sun (12 shared papers)Jinlu Huang (12 shared papers)Linlin Chen (5 shared papers)Yan Huo (7 shared papers)Hong Zhang (3 shared papers)
- Journals
- RSC Advances (3 papers)Molecular Therapy (3 papers)Advanced Healthcare Materials (2 papers)Frontiers in Pharmacology (2 papers)Phytotherapy Research (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Quanjun Yang
71 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 378
- Molecular Biology 805
- Cancer Research 166
- Geriatrics and Gerontology 42
- Physiology 262
Countries citing papers authored by Quanjun Yang
This map shows the geographic impact of Quanjun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanjun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanjun Yang more than expected).
Fields of papers citing papers by Quanjun Yang
This network shows the impact of papers produced by Quanjun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanjun Yang. The network helps show where Quanjun Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Quanjun Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 148 | |
| 2 | A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy Hit paper breakdown → | 2022 | 143 |
| 3 | 2017 | 124 | |
| 4 | 2020 | 121 | |
| 5 | 2016 | 49 | |
| 6 | 2017 | 44 | |
| 7 | 2021 | 38 | |
| 8 | 2019 | 37 | |
| 9 | 2022 | 36 | |
| 10 | 2020 | 34 | |
| 11 | 2019 | 34 | |
| 12 | 2016 | 34 | |
| 13 | 2017 | 33 | |
| 14 | 2020 | 33 | |
| 15 | 2016 | 31 | |
| 16 | 2022 | 24 | |
| 17 | 2012 | 23 | |
| 18 | 2022 | 22 | |
| 19 | 2016 | 22 | |
| 20 | 2014 | 22 |
About Quanjun Yang
Quanjun Yang is a scholar working on Molecular Biology, Oncology, Physiology, Immunology and Pharmacology, having authored 76 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nutrition and Health in Aging (14 papers), Muscle Physiology and Disorders (12 papers), CAR-T cell therapy research (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Immune Cell Function and Interaction (4 papers), Adipose Tissue and Metabolism (4 papers), CRISPR and Genetic Engineering (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Oncology (378 citations), Molecular Biology (805 citations), Cancer Research (166 citations), Geriatrics and Gerontology (42 citations) and Physiology (262 citations). Quanjun Yang has collaborated with scholars based in China, United States and France. Frequent co-authors include Cheng Guo, Lili Wan, Yonglong Han, Xipeng Sun, Jinlu Huang, Linlin Chen, Yan Huo, Hong Zhang, Jinmiao Lu and Lupeng Ye. Their work appears in journals such as RSC Advances, Molecular Therapy, Advanced Healthcare Materials, Frontiers in Pharmacology and Phytotherapy Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.